Having identified the critical roles of PLSCR1 in breast cancer, we determined the association of PLSCR1 expression with chemotherapy sensitivity in the GSE25066 dataset in which patients with breast cancer received chemotherapy including sequential taxane and anthracycline-based regimens. This evidence concerns the gene PLSCR1 and breast carcinoma.